Home › NDC Lookup › RxCUI directory › RxCUI 213071

Sennosides, USP 15 MG Chewable Tablet [Ex-Lax Chocolated] — RxCUI 213071

RxNorm drug concept · Semantic branded drug
RxCUI 213071 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI213071
Official nameSennosides, USP 15 MG Chewable Tablet [Ex-Lax Chocolated]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asEx-Lax Chocolated 15 MG Chewable Tablet; Ex-Lax Regular Strength Chocolated 15 MG Chewable Tablet
FDA products mapped1
Package NDCs mapped3
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Senna: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Senna typically produces a bowel movement within 6 to 12 hours. That's why most people take it at bedtime — so it can do its job overnight and you get results in the morning. If no...
  • How long does it take for senna to work?
  • Senna is designed for short-term, occasional use. You should not use it for more than 1 week unless your doctor specifically tells you it's okay. Using laxatives too often or for t...
  • Laxatives like senna can affect how your body absorbs other medications. To be safe, take senna at least 2 hours before or after any other drugs you use. It's always a good idea to...
📖 Read our full Senna guide →

🕸️ Concept Web — How Sennosides, USP 15 MG Chewable Tablet [Ex-Lax Ch... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Sennosides, USP 15 MG Chewable Tablet [Ex-Lax Chocolated] RxCUI 213071

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Sennosides, USP 36387
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Ex-Lax Chocolated 217013
  3. Dose forms 12

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Sennosides, USP Chewable Tablet 373857
    • Sennosides, USP Chewable Product 1294747
    • Sennosides, USP Oral Product 1159068
    • Sennosides, USP Pill 1159069
    • Sennosides, USP Chewable Tablet [Ex-Lax Chocolated] 369658
    • Ex-Lax Chocolated Chewable Product 1296242
    • Ex-Lax Chocolated Oral Product 1171828
    • Ex-Lax Chocolated Pill 1171829
    • +4 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 17 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Sennosides, USP 15 MG Chewable Tablet SCD · 251020
  • Sennosides, USP 15 MG SCDC · 331425
  • Sennosides, USP Chewable Tablet SCDF · 373857
  • Sennosides, USP Chewable Product SCDG · 1294747
  • Sennosides, USP Oral Product SCDG · 1159068
  • Sennosides, USP Pill SCDG · 1159069

Brand-Name Concepts

  • Sennosides, USP 15 MG [Ex-Lax Chocolated] SBDC · 573006
  • Sennosides, USP Chewable Tablet [Ex-Lax Chocolated] SBDF · 369658
  • Ex-Lax Chocolated Chewable Product SBDG · 1296242
  • Ex-Lax Chocolated Oral Product SBDG · 1171828
  • Ex-Lax Chocolated Pill SBDG · 1171829
  • Ex-Lax Chocolated BN · 217013

📦 FDA Products & Package NDCs

1 product · 3 package NDCs
3 package NDCs map to RxCUI 213071 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00067-8140-01 1 PACKAGE in 1 BOX (0067-8140-01) / 12 TABLET, CHEWABLE in... EX-LAX REGULAR STRENGTH CHOCOLATED STIMULANT LAXATIVE Haleon US Holdings LLC 2017-08-01
00067-8140-02 2 PACKAGE in 1 BOX (0067-8140-02) / 12 TABLET, CHEWABLE in... EX-LAX REGULAR STRENGTH CHOCOLATED STIMULANT LAXATIVE Haleon US Holdings LLC 2017-08-01
00067-8140-03 4 PACKAGE in 1 BOX (0067-8140-03) / 12 TABLET, CHEWABLE in... EX-LAX REGULAR STRENGTH CHOCOLATED STIMULANT LAXATIVE Haleon US Holdings LLC 2017-08-01
Observed labelers: Haleon US Holdings LLC (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.